Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver
about
Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density GradientsHepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic CellPreferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteinsBinding of liver derived, low density hepatitis C virus to human hepatoma cellsCharacterization of hepatitis C RNA-containing particles from human liver by density and sizeIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesSecretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive LipoproteinsHuman cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virionsNeutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.Hepatitis C virus: virology and life cycleHCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine developmentCharacterization of Nora Virus Structural Proteins via Western Blot Analysis.Primary hepatocytes as targets for hepatitis C virus replication.Emerging therapies for hepatitis C virus.HCV entry receptors as potential targets for siRNA-based inhibition of HCV.The role of HCV proteins on treatment outcomes.Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV.Signal peptide peptidase-catalyzed cleavage of hepatitis C virus core protein is dispensable for virus budding but destabilizes the viral capsid.Generation and epitope mapping of a sub-group cross-reactive anti-respiratory syncytial virus G glycoprotein monoclonal antibody which is protective in vivo.Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.Newly discovered hepatitis C virus minicores circulate in human blood.Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries
P2860
Q27473044-39E74274-3D57-4B4A-9E95-110E0B81044DQ27478174-DE7A35B0-A71A-4857-B5B6-019AD620E459Q27481398-EC18DFE2-42B2-48AB-909D-5EF29AE3CE64Q27486525-D45384F1-BAB6-4033-B64E-24F46CF2F60FQ27486986-8D74C146-B357-4A34-B719-F2CDA736EF30Q27487399-41D1BF89-1E2C-48F9-A6D6-16E33F58BF4BQ27487558-F1EEC7C1-44BD-4EFC-A83D-C85167B5E5F4Q35124736-02115074-B124-44AA-8600-C164A04AA003Q35212817-CCD542CF-2009-41F0-BACA-295E854E0017Q35231331-BE7C2BB9-40A0-4CBF-B91B-8DA70A1E901DQ35769705-F1DD8341-273A-4C0D-8E73-925F583EA738Q36756358-16F3A395-301D-4C1D-83CE-72F997C61384Q36874176-A637B25F-846D-4523-9984-495C026176C4Q36958837-13686E10-1A1B-4107-98C7-EA7EC6D3245EQ37352203-888D5C34-B528-488A-9386-54458084DB76Q37772514-427F8F2F-367F-42C2-BE5B-969208299B26Q38557431-51B85ED9-0873-4917-879D-3C37F01230E8Q38668968-3D29BA57-3FA4-414F-992E-88856D694E6DQ39526744-267D06D9-35D0-417F-A5A6-EB4BED17C16EQ42036653-0A982DDF-9020-4963-AD60-316648AC990EQ42243843-DFDB2F6E-F3A6-4E28-813D-6916ACF6BA91Q45324832-12CF2D64-90FB-4A93-A7A1-6AA0DAEAA2B4Q45399951-244A398B-B8DB-4C23-9F77-A15F607F7DC1Q52699061-2714AE17-52B3-4007-9DDC-1FEF4B674023Q56480896-64F73226-609C-4145-A1CA-F43A9D94793E
P2860
Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of the genome ...... lved from infected human liver
@ast
Characterization of the genome ...... lved from infected human liver
@en
Characterization of the genome ...... lved from infected human liver
@nl
type
label
Characterization of the genome ...... lved from infected human liver
@ast
Characterization of the genome ...... lved from infected human liver
@en
Characterization of the genome ...... lved from infected human liver
@nl
prefLabel
Characterization of the genome ...... lved from infected human liver
@ast
Characterization of the genome ...... lved from infected human liver
@en
Characterization of the genome ...... lved from infected human liver
@nl
P2093
P2860
P3181
P356
P1476
Characterization of the genome ...... lved from infected human liver
@en
P2093
Alastair D Burt
Debra J Bevitt
Geoffrey L Toms
Margaret F Bassendine
Søren U Nielsen
P2860
P304
P3181
P356
10.1099/VIR.0.79967-0
P407
P577
2004-06-01T00:00:00Z